EV/EBITDA
-7.84
+0.34+4.16%
Tue, 25 Feb 2025 23:04:11 GMT
Summary
- As of February 26, 2025, IKT EV/EBITDA is -7.84, with a rise of +0.34 (+4.16%) during the most recent trading day.
- Over the past year, IKT EV/EBITDA has dropped by -7.61 (-3308.70%).
- IKT EV/EBITDA is now -737.40% below its all-time high of 1.23.
Performance
IKT EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
IKT EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +4.2% | -4.1% | -4.1% |
| 1 m1 month | +16.4% | -16.4% | -16.4% |
| 3 m3 months | -0.9% | +0.9% | +0.9% |
| 6 m6 months | -1766.7% | +1885.5% | +62.1% |
| ytdytd | +27.8% | -27.8% | -27.7% |
| 1 y1 year | -3308.7% | +3392.4% | +8.3% |
| 5 y5 years | - | - | - |
IKT EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -14.1% | -10.29 | +23.8% | |
| 3 m | 3-month | -6.87 | -14.1% | -13.44 | +41.7% |
| 6 m | 6-month | -0.30 | -2513.3% | -13.44 | +41.7% |
| 1 y | 1-year | -0.18 | -4255.6% | -13.44 | +41.7% |
| 3 y | 3-year | 1.23 | -737.4% | -13.44 | +41.7% |
| 5 y | 5-year | 1.23 | -737.4% | -49.12 | +84.0% |
| alltime | all time | 1.23 | -737.4% | -49.12 | +84.0% |
Inhibikase Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | -7.84(-27.8%) |
| 2024 | -10.86(<-9900.0%) |
| 2023 | 0.06(-118.8%) |
| Date | Value |
|---|---|
| 2022 | -0.32(-233.3%) |
| 2021 | 0.24(-101.2%) |
| 2020 | -19.77 |
FAQ
- What is Inhibikase Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Inhibikase Therapeutics?
- What is IKT EV/EBITDA year-to-date change?
- What is Inhibikase Therapeutics EV/EBITDA year-on-year change?
What is Inhibikase Therapeutics EV/EBITDA?
The current EV/EBITDA of IKT is -7.84
What is the all time high EV/EBITDA for Inhibikase Therapeutics?
Inhibikase Therapeutics all-time high EV/EBITDA is 1.23
What is IKT EV/EBITDA year-to-date change?
Inhibikase Therapeutics EV/EBITDA has changed by +3.02 (+27.81%) since the beginning of the year
What is Inhibikase Therapeutics EV/EBITDA year-on-year change?
Over the past year, IKT EV/EBITDA has changed by -7.61 (-3308.70%)